Prognostic and diagnostic anthropometric biomarkers of sarcopenia in a cohort of Egyptian patients with hepatitis C-induced liver cirrhosis

Egyptian Liver Journal

Table 3 Comparison and validity of anthropometrics among CTP groups (n = 80)

	Total (n = 80)	CTP			χ²	P	Validity
	Total (n = 80)	A (n = 12)	B (n = 32)	C (n = 36)	χ²	P	Validity
Probable sarcopenia
LES	61 (76%)	8 (66.7%)	24 (75%)	29 (81%)	1.005	0.605
HGS	72 (90%)	10 (83.3%)	26 (81.3%)	36 (100%)	8.355^*	^MCp = 0.010^*
Overall probable	76 (95%)	10 (83.3%)	30 (93.8%)	36 (100%)	5.022^*	^MCp = 0.033^*
Definitive sarcopenia
LES/MCC	51 (64%)	3 (25.0%)	18 (56.3%)	30 (83%)	14.550^*	0.001^*	0.001^*
LES/MAMC	58 (73%)	9 (75%)	23 (71.9%)	26 (72%)	0.045	0.978	0.960
HGS/MCC	50 (63%)	1 (8.3%)	20 (62.5%)	29(81%)	20.030^*	< 0.001^*	0.003^*
HGS/MAMC	55 (69%)	7 (58.3%)	21 (65.6%)	27 (75%)	1.406	0.495	0.275
Overall definitive	76 (95%)	10 (83%)	31 (96.9%)	35 (97%)	3.336	^MCp = 0.198	^FEp = 0.623

χ² chi-square test, MC Monte Carlo, p p value for comparing between CTP and different parameters, FE Fisher’s exact test
^*Statistically significant at p ≤ 0.05